Pohl, Heiko http://orcid.org/0000-0002-2778-6790
Gantenbein, Andreas R.
Sandor, Peter S.
Andrée, Colette
Funding for this research was provided by:
Migraine Action Switzerland (N/A)
Swiss Headache Society (N/A)
Werner Dessauer Stiftung (N/A)
Research Fund of the RehaClinic Group (N/A)
Teva Pharmaceutical Industries (N/A)
Novartis (N/A)
Eli Lilly and Company (N/A)
Article History
Accepted: 24 September 2020
First Online: 6 October 2020
Compliance with Ethical Standards
:
: The authors report the following conflicts of interest with respect to the research, authorship and/or publication of this article.Dr. Pohl reports other from Teva Pharmaceutical Industries Ltd., and Eli Lilly, grants from Werner Dessauer Stiftung, outside the submitted work. Dr. Gantenbein reports personal fees from Grünenthal, Eli Lilly, Novartis and Teva Pharmaceutical Industries Ltd., outside the submitted work. Dr. Sandor reports personal fees from Novartis, personal fees from Teva Pharmaceutical Industries Ltd., personal fees from Lilly and personal fees from Almirall, outside the submitted work. Dr. Andrée has nothing to disclose.